ARTV vs. CGON

Last updated Apr 2, 2026

Compare and contrast key facts about Artiva Biotherapeutics, Inc (ARTV) and CG Oncology, Inc (CGON).

Performance

ARTV vs. CGON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Artiva Biotherapeutics, Inc (ARTV) and CG Oncology, Inc (CGON). The values are adjusted to include any dividend payments, if applicable.

ARTV vs. CGON - Yearly Performance Comparison

	2026 (YTD)	2025	2024
ARTV Artiva Biotherapeutics, Inc	57.34%	-57.44%	-16.00%
CGON CG Oncology, Inc	60.86%	44.77%	-18.57%

Fundamentals

EPS ARTV : -$2.96 CGON : -$2.10
Total Revenue (TTM) ARTV : $0.00 CGON : $4.04M
Gross Profit (TTM) ARTV : -$662.00K CGON : -$607.00K
EBITDA (TTM) ARTV : -$82.23M CGON : -$167.30M

Returns By Period

In the year-to-date period, ARTV achieves a 57.34% return, which is significantly lower than CGON's 60.86% return.

ARTV

• 1D: 4.81%
• 1M: 16.98%
• YTD: 57.34%
• 6M: 131.16%
• 1Y: 125.00%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CGON

• 1D: -1.32%
• 1M: 15.63%
• YTD: 60.86%
• 6M: 69.26%
• 1Y: 202.90%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ARTV vs. CGON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARTV

ARTV Risk / Return Rank: 76
ARTV Sharpe Ratio Rank: 63
ARTV Sortino Ratio Rank: 87
ARTV Omega Ratio Rank: 84
ARTV Calmar Ratio Rank: 78
ARTV Martin Ratio Rank: 71

CGON

CGON Risk / Return Rank: 94
CGON Sharpe Ratio Rank: 96
CGON Sortino Ratio Rank: 93
CGON Omega Ratio Rank: 93
CGON Calmar Ratio Rank: 94
CGON Martin Ratio Rank: 96

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ARTV vs. CGON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Artiva Biotherapeutics, Inc (ARTV) and CG Oncology, Inc (CGON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ARTV	CGON	Difference
Sharpe ratio Return per unit of total volatility	0.66	2.90	-2.24
Sortino ratio Return per unit of downside risk	2.63	3.30	-0.67
Omega ratio Gain probability vs. loss probability	1.34	1.46	-0.13
Calmar ratio Return relative to maximum drawdown	2.25	5.78	-3.53
Martin ratio Return relative to average drawdown	3.95	18.95	-15.00
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ARTV vs. CGON - Sharpe Ratio Comparison

The current ARTV Sharpe Ratio is 0.66, which is lower than the CGON Sharpe Ratio of 2.90. The chart below compares the historical Sharpe Ratios of ARTV and CGON, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ARTV	CGON	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.66	2.90	-2.24
Sharpe Ratio (All Time) Calculated using the full available price history	-0.18	0.48	-0.66

Correlation

The correlation between ARTV and CGON is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ARTV vs. CGON - Dividend Comparison

Neither ARTV nor CGON has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ARTV vs. CGON - Drawdown Comparison

The maximum ARTV drawdown since its inception was -90.71%, which is greater than CGON's maximum drawdown of -67.47%. Use the drawdown chart below to compare losses from any high point for ARTV and CGON.

Drawdown Indicators

	ARTV	CGON	Difference
Max Drawdown Largest peak-to-trough decline	-90.71%	-67.47%	-23.24%
Max Drawdown (1Y) Largest decline over 1 year	-55.59%	-29.90%	-25.69%
Current Drawdown Current decline from peak	-57.36%	-2.70%	-54.66%
Average Drawdown Average peak-to-trough decline	-60.12%	-27.31%	-32.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.62%	9.11%	+22.51%

Volatility

ARTV vs. CGON - Volatility Comparison

Artiva Biotherapeutics, Inc (ARTV) has a higher volatility of 31.76% compared to CG Oncology, Inc (CGON) at 13.04%. This indicates that ARTV's price experiences larger fluctuations and is considered to be riskier than CGON based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ARTV	CGON	Difference
Volatility (1M) Calculated over the trailing 1-month period	31.76%	13.04%	+18.72%
Volatility (6M) Calculated over the trailing 6-month period	126.68%	42.73%	+83.95%
Volatility (1Y) Calculated over the trailing 1-year period	191.03%	71.14%	+119.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	160.74%	65.24%	+95.50%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	160.74%	65.24%	+95.50%

Financials